A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.
Citi said the company's announcement of generic Rivaroxaban 2.5 mg (Xarelto 2.5mg) tablets in the US is an "at risk" launch ...
Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...
This follows the final approval from the US FDA for its abbreviated new drug application (ANDA). Shares of Lupin Ltd ended at ...
Lupin 's Omar Sy has been cast in a new Netflix offshoot of a popular action franchise. The star will lead a "high-octane" ...
Here’s how it works. The hit Netflix thriller series Lupin will potentially be returning – but perhaps not in the way fans might have been expecting. The French crime drama became one of ...
Buy Lupin Futures, SL 2000 Tgt 2050, 2070, Generic heart disease drug 'Rivaroxaban' launched in US, Nomura maintains Buy ...
However, things start to unravel for Zoe as she deals with mounting pressure, work mishaps and personal problems. As well as ...
Quarterly Net Profit at Rs. 855.16 crore in December 2024 up 39.48% from Rs. 613.12 crore in December 2023. EBITDA stands at ...
Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback